Table 2.

Adjuvant chemotherapy for non-metastatic patients and outcome.

Patient number, age	Regimes	Cycles	DFS (months)	LV invasion	Ki-67 index	Metastasis
1 60-69 years	GEM	4	5	Yes	70%	Yes
1 50-59 years	GEM	4	5	Yes	Unknown	Yes
1 50-59 years	S1	2	26	Yes	Unknown	Yes
2 50-59 years	GEMOX	2	27	Yes	30%	Yes
1 50-59 years	GEM	10	57	No	30%	Yes
2 40-49 years	S1	12	51	No	15%	No
1 50-59 years	SOX	5	62	No	20%	No
1 10-19 years	GEM	4	141	No	10%	No

Abbreviations: DFS, disease-free survival; GEM, gemcitabine; GEMOX, gemcitabine + oxaliplatin; LV, lymph-vascular; S1, tegafur/gimeracil/potassium; SOX, S1 + oxaliplatin.

1/2 in Column 1 refers to sex (male or female).